Non-infectious Pulmonary Complications in Children with Primary Immunodeficiency

Overview

Journal Clin Med Insights Pediatr

Publisher Sage Publications

Specialty Pediatrics

Date 2023 Sep 11

PMID 37692068

Authors

Wimwipa Mongkonsritragoon

Ruma Srivastava

Divya Seth

Aishwarya Navalpakam

Pavadee Poowuttikul

Affiliations

Soon will be listed here.

Abstract

Primary immune deficiency (PID) is a large group of diseases characterized by defective immune function, leading to recurrent infections, and immune dysregulation. Clinical presentations, severity, and complications differ for each disease, based on the components of the immune system that are impacted. When patients with PID present with respiratory symptoms, infections should be initially suspected, investigated, and promptly managed. However, non-infectious complications of PID also frequently occur and can lead to significant morbidity and mortality. They can involve both the upper and lower respiratory systems, resulting in various presentations that mimic infectious diseases. Thus, clinicians should be able to detect these conditions and make an appropriate referral to an immunologist and a pulmonologist for further management. In this article, we use case-based scenarios to review the differential diagnosis, investigation, and multidisciplinary treatment of non-infectious pulmonary complications in patients with primary immune deficiencies.

References

Yao Q, Zhou Q, Shen Q, Qiao Z, Wang X, Hu X . Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999-2018). Sci Rep. 2020; 10(1):19349. PMC: 7652842. DOI: 10.1038/s41598-020-76408-4. View

Chowdhury M, Anstey A, Matthews C . The dermatosis of chronic granulomatous disease. Clin Exp Dermatol. 2000; 25(3):190-4. DOI: 10.1046/j.1365-2230.2000.00610.x. View

Boursiquot J, Gerard L, Malphettes M, Fieschi C, Galicier L, Boutboul D . Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2012; 33(1):84-95. DOI: 10.1007/s10875-012-9778-9. View

Lugo Reyes S, Suarez F, Herbigneaux R, Pacquement H, Reguerre Y, Riviere J . Hodgkin lymphoma in 2 children with chronic granulomatous disease. J Allergy Clin Immunol. 2010; 127(2):543-544.e1-3. PMC: 3038468. DOI: 10.1016/j.jaci.2010.10.049. View

Ng J, Wright K, Alvarez M, Hunninghake G, Wesemann D . Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease. Chest. 2019; 155(5):e117-e121. PMC: 6689079. DOI: 10.1016/j.chest.2019.01.034. View

Pathria M, Urbine D, Zumberg M, Guarderas J . Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency. BMJ Case Rep. 2016; 2016. PMC: 4932434. DOI: 10.1136/bcr-2016-215624. View

Deya-Martinez A, Esteve-Sole A, Velez-Tirado N, Celis V, Costa J, Cols M . Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells. Pediatr Allergy Immunol. 2018; 29(4):425-432. DOI: 10.1111/pai.12890. View

Orange J, Hossny E, Weiler C, Ballow M, Berger M, Bonilla F . Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006; 117(4 Suppl):S525-53. DOI: 10.1016/j.jaci.2006.01.015. View

Valery P, Torzillo P, Mulholland K, Boyce N, Purdie D, Chang A . Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J. 2004; 23(10):902-8. DOI: 10.1097/01.inf.0000142508.33623.2f. View

10.

Lopes J, Ho H, Cunningham-Rundles C . Interstitial Lung Disease in Common Variable Immunodeficiency. Front Immunol. 2021; 12:605945. PMC: 7990881. DOI: 10.3389/fimmu.2021.605945. View

11.

Wolach B, Gavrieli R, de Boer M, van Leeuwen K, Berger-Achituv S, Stauber T . Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients. Am J Hematol. 2016; 92(1):28-36. DOI: 10.1002/ajh.24573. View

12.

Bang T, Richards J, Olson A, Groshong S, Gelfand E, Lynch D . Pulmonary Manifestations of Common Variable Immunodeficiency. J Thorac Imaging. 2018; 33(6):377-383. DOI: 10.1097/RTI.0000000000000350. View

13.

Tanaka N, Kim J, Bates C, Brown K, Cool C, Newell J . Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. J Comput Assist Tomogr. 2006; 30(5):828-38. DOI: 10.1097/01.rct.0000228163.08968.26. View

14.

Verbsky J, Hintermeyer M, Simpson P, Feng M, Barbeau J, Rao N . Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. J Allergy Clin Immunol. 2020; 147(2):704-712.e17. DOI: 10.1016/j.jaci.2020.07.021. View

15.

Arish N, Eldor R, Fellig Y, Bogot N, Laxer U, Izhar U . Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins. Thorax. 2006; 61(12):1096-7. PMC: 2117067. DOI: 10.1136/thx.2004.029819. View

16.

Salvator H, Mahlaoui N, Catherinot E, Rivaud E, Pilmis B, Borie R . Pulmonary manifestations in adult patients with chronic granulomatous disease. Eur Respir J. 2015; 45(6):1613-23. DOI: 10.1183/09031936.00118414. View

17.

Shinzato Tatebe M, de Barros Dorna M, Castro A, Pastorino A . Inflammatory manifestations in children with chronic granulomatous disease. Pediatr Allergy Immunol. 2021; 32(5):1117-1120. DOI: 10.1111/pai.13487. View

18.

Pacheco S, Stark J . Pulmonary Manifestations of Immunodeficiency and Immunosuppressive Diseases Other than Human Immunodeficiency Virus. Pediatr Clin North Am. 2020; 68(1):103-130. DOI: 10.1016/j.pcl.2020.09.004. View

19.

Campos L, Di Colo G, Dattani V, Braggins H, Kumararatne D, Williams A . Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom. J Allergy Clin Immunol. 2020; 147(3):1104-1107. DOI: 10.1016/j.jaci.2020.08.034. View

20.

Cinetto F, Scarpa R, Pulvirenti F, Quinti I, Agostini C, Milito C . Appropriate lung management in patients with primary antibody deficiencies. Expert Rev Respir Med. 2019; 13(9):823-838. DOI: 10.1080/17476348.2019.1641085. View